Causes of rise of troponin after percutaneous coronary intervention and its clinical implication

To analyse the clinical factors that contribute to the rise of the cardiac injury marker troponin after coronary intervention and the impact of the rise of troponin on the clinical outcomes. Troponin I was measured after elective coronary intervention in 129 patients whose baseline levels of troponi...

Full description

Saved in:
Bibliographic Details
Published inSichuan da xue xue bao. Journal of Sichuan University. Yi xue ban Vol. 39; no. 1; p. 126
Main Authors He, Yong, Zheng, Ming-xia, Cui, Kai-jun, Zhang, Li, Feng, Yuan, Hu, Hong-de, Huang, De-jia
Format Journal Article
LanguageChinese
Published China 01.01.2008
Subjects
Aged
Angina Pectoris - epidemiology
Angioplasty, Balloon, Coronary - adverse effects
Diabetes Mellitus - epidemiology
Female
Humans
Incidence
Length of Stay
Male
Middle Aged
Myocardial Infarction - epidemiology
Risk Factors
Treatment Outcome
Troponin I - blood
Online AccessGet more information

Cover

More Information
Summary:To analyse the clinical factors that contribute to the rise of the cardiac injury marker troponin after coronary intervention and the impact of the rise of troponin on the clinical outcomes. Troponin I was measured after elective coronary intervention in 129 patients whose baseline levels of troponin were normal. The clinical outcomes of the patients were follow-up. The rise of troponin I was associated with side branch losses, flow impairments such as no flow or slow flow and diabetes. The incidence of myocardial infarction increased with the rise of troponin I. The angina onsets were more common and the length of stay were longer in the patients with the rise of troponin I than those without. The rise of troponin after coronary intervention is related to the complex coronary lesions and the complications of intervention procedures. To a certain extent, the level of troponin can predict the patients' outcomes.
ISSN:1672-173X